Xeris Pharmaceuticals Inc (XERS) — Cash Flow Reinvestment Rate
Xeris Pharmaceuticals Inc (XERS) has a Cash Flow Reinvestment Rate of 0.03x as of June 2026, reinvesting $209.00K (capex $209.00K ) from operating cash flow of $8.26 Million. See XERS FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Xeris Pharmaceuticals Inc Cash Flow Reinvestment Rate (2025–2025)
Historical reinvestment intensity for Xeris Pharmaceuticals Inc across 1 annual periods. For the full cash flow conversion analysis, see Xeris Pharmaceuticals Inc operating cash flow efficiency.
Annual Cash Flow Reinvestment Rate for Xeris Pharmaceuticals Inc (2025–2025)
Year-by-year capital reinvestment analysis for Xeris Pharmaceuticals Inc. See XERS free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.02x | $696.00K | $28.63 Million | $696.00K | — |